Sandosh Padmanabhan

Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

Bryan Williams, Thomas M. MacDonald, S. V. Morant et al. · The Lancet · 2015 · 1.2K citations · Full text

Genetically Distinct Subsets within ANCA-Associated Vasculitis

Paul Lyons, Tim F. Rayner, Sapna Trivedi et al. · New England Journal of Medicine · 2012 · 1K citations · Full text

Rare and low-frequency coding variants alter human adult height

Eirini Marouli, Mariaelisa Graff, Carolina Medina‐Gómez et al. · Nature · 2017 · 647 citations · Full text

Allelic Variant, Genetics, Statistical Genetics +2

Polygenic Risk Score Identifies Subgroup With Higher Burden of Atherosclerosis and Greater Relative Benefit From Statin Therapy in the Primary Prevention Setting

Pradeep Natarajan, Robin Young, Nathan O. Stitziel et al. · Circulation · 2017 · 555 citations · Full text

Risk HLA-DQA1 and PLA ₂ R1 Alleles in Idiopathic Membranous Nephropathy

H.C. Stanescu, Mauricio Arcos‐Burgos, Alan Medlar et al. · New England Journal of Medicine · 2011 · 508 citations · Full text